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Dendritic cells (DC)' are potent initiators ofT cell responses to alloantigens (1-4)
or haptens (5-8) in vivoorin vitro usingnormal mice. On first stimulation in vitro,
cells from normal animals show strong reactivity for these antigens by CD4+ , class
II MHC-restricted cells. They also have a high precursor frequency of cytotoxic T
cells(CTL) restricted by class I MHC antigens (e.g., reference 9), presumably selected
through the antigenic history of the individual. Using infectious viruses it has not
been possible so far to obtain primary T cell responses in vitro. However, DC ex-
posed to live virus are very effective APC in vitro for secondary, antiviral responses
(10, 11). In addition, Kast et al. (11) have been able to overcome CTL nonresponsive-
ness to Moloney virus in Db mutant bm 14 mice by stimulating T cells from virus-
primed animals with Moloney virus-infected DC in vitro. However, this protocol
did not result in CTL generation to Sendai virus in bm 1 nonresponder mice.
We wished to know whether DC exposed to infectious virus were able to induce
a primary, virus-specific, proliferative and CTL response. We chose the well-defined
influenza system as a model for these experiments, since both Th and CTL assays
and some of the viral specificities of these cells have been defined in mice (12, 13).
DC were exposed to type A influenza virus or to a nucleoprotein (NP) peptide (14)
recognized by BALB/c influenza-specific CTL. T cellsfrom lymph nodes of normal
specific pathogen-free (SPF) mice were stimulated with these DC in hanging drop
cultures (15) that show highly efficient lymphocyte proliferation. The present study
reveals that in such cultures, DC, infected with influenza in vitro or in vivo, at 0.1-1To
of the number of responder T cells, resulted within 3 d in a strong proliferative re-
sponse, and by 5 d in the generation of influenza-specific CTL that lysed influenza
virus-infected targets. The CTL recognized the same NP peptide epitope as BALB/c
CTL primed by infection (16). The NP peptide-pulsed DC also induced an antiviral
CTL response. In contrast, peritoneal exudate macrophages (MO) infected with
influenza did not generate a primary CTL response, although both MO and DC
induced a secondary CTL response in spleen cells from mice that had been primed
in vivo by influenza infection.
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Materials and Methods
Antigens.
￿
Influenza virus A/X31 was grown in the allantoic cavity of 10-d-old chick em-
bryos and stored as infectious allantoic fluid at -70°C. The influenza NP peptide 147-158
(Arg,56-) has been previously described as a potent epitope for NP-specific CTL in BALB/c
mice (14).
Virus Infection ofMice.
￿
3-4-mo-old BALB/c or CBA/Ca mice were bred under SPF condi-
tions at the National Institute for Medical Research (London). In addition to the normal
mice used for primary antigen responses, mice that had been intranasally primed with A/X31
influenza virus (2-5 hemagglutination units [HAU]/mouse), 1-3 mo previously, were used
for secondary antigen responses.
Responder T Cells.
￿
The lymph nodes (inguinal, axillary, and popliteal) were taken from
normal SPF mice. Single cell suspensions were prepared by pressing the tissue through wire
mesh and washing in medium (RPMI 1640 [Dutch modification] with 100 IU/ml of peni-
cillin, 100 hg/ml streptomycin, 10-5 M 2-ME, and 10% FCS). Enriched T cells 85% pure
(8) were obtained by passage of cell suspensions over nylon wool columns.
For secondary in vitro responses, T cells were purified as above from spleens ofmice primed
by intranasal influenza infection.
APC.
￿
DC were isolated from nonadherent spleen cells after overnight culture in medium
in tissue culture flasks, or from freshly prepared lymph node cell suspensions (8, 17). The
cells (5-8 ml) at 5 x 106/ml were layered onto 2-ml metrizamide gradients (Nyegaard, Oslo,
Norway; analytical grade, 14.5 g added to 100 ml medium) and centrifuged at 600 g for 10
min. These separated cells were >80% DC, assessed by morphology and sensitivity to lysis
with a specific antibody for DC (33131; reference 18) plus C (Buxted Rabbit Co., Sussex,
UK) used at a concentration of 1 :10. Less than 3olo were macrophages that labeled with the
mAb F4/80 (19) and there were small numbers of contaminating lymphocytes (5-8).
Peritoneal exudate cells (PEC) were taken from animals 3 d after intraperitoneal injection
of 60 jig Con A and were used as a source of macrophages expressing class II MHC mole-
cules. Morphologically, 50% of the PEC were DC, which were removed by treatment with
the DC-specific mAb 33DI plus C, leaving mainly macrophages.
DC or PEC were untreated or infected in vitro in serum-free RPMI 1640 medium with
influenza virus A/X31 (100 HAU/106 cells) for 45 min and then washed twice in medium.
Alternatively, DC were pretreated at 37°C with 10-6 or 10' M influenza NP peptide
(147-158 Arg, 56- ) for 45 min, and washed twice in medium; some DC were treated with the
contact sensitizer FITC (8) (Isomer 1, Sigma Chemical Co., St. Louis, MO) (12 .5 Fig/ml for
20 min at 37°C). DC exposed to antigen in vivo were isolated from the peripheral lymph
nodes of mice that had been injected with 2 HAU A/X31 into each footpad and also infected
intranasally with 2 HAU A/X31, 24 h previously.
Lymphocyte Proliferation In Vitro.
￿
Cultures contained 2 .5-10 x 104 T cells (from normal
mice or from mice primed intranasally by A/X31 infection) and varying numbers of DC
or macrophages as stimulator cells, untreated or treated with influenza virus. Cultures (20
ul) were in 10-Al wells of Terasaki plates, inverted so that cells rested on the meniscus ofhanging
drops and were placed above sterile saline in loose-topped plastic boxes in a 37°C, well-
humidified and gassed incubator (15). After 3 d, cultures were pulsed with [3H]TdR (Amer-
sham International, Amersham, UK) (2 Ci/mM, final concentration of 1 lcg of thymidine)
by expelling 1 gl of thymidine onto the tip of a 25-gauge needle attached to a repeating sy-
ringe (Hamilton Co., Reno, NV) and bringing this up towards the side of a hanging culture
until the drop ofthymidine disappeared into the culture. After 2 h the cultures were simply
blotted onto 60 filter discs that had been cut in a harvester plate (Bioengineering Workshops,
Clinical Research Centre, Harrow, UK) using the raised rims of a dry Terasaki plate as a
cutter. Alternatively, filter discs were cut in a harvester plate using a metal cutter (Flow Labora-
tories, Inc., McLean, VA). The filters were washed in the harvester plate which was applied
to a vacuum box attached to a tap pump. Approximately 10 ml saline and 10 ml 5% TCA
were added from wash bottles and the filters were dried with alcohol (15) and counted in
a scintillation counter.
Induction ofInfluenza Virus-speck CTL In Vitra
￿
Purified T cells from lymph nodes ofnormal
BALB/c mice were cultured in 20-/Al hanging drops as above (105 T cells/droplet) in RPMI1640 medium and stimulated with 101 DC infected in vitro with A/X31 influenza virus (100
HAU/ 106 DC). After 5 d 60 drops were pooled for the cytotoxicity assays. For secondary
in vitro stimulations, splenic T cells from mice primed with infection (106/ml) were stimu-
lated with DC or peritoneal exudate cells as indicated in 4 ml medium in Bijou bottles (7
ml) (Sterilin, Teddington, UK).
Cytotoxicity Assays.
￿
After 5 d, cultures in Bijoux or hanging dropswere harvested and CTL
activity was assayed using a "Cr release assay (12). Target cells were "Cr-labeled P815 (H-2d)
cells untreated, infected with A/X31 for 1 h, or pulsed with 10' M NP peptide (147-158
Arg,56 - ) for 45 min at 37°C, followed by three washes before use.
After a 6-h cytotoxicity assay, percent specific "Cr release from lysed target cells, was cal-
culated as: 100 x [cpm (sample release) - cpm (spontaneous release)]/[cpm (total release)
- cpm (spontaneous release)]. Spontaneous "Cr release from targets in the absence ofCTL
was <107o.
Results
DC purified from spleen and infected with influenza virus in vitro stimulated a
strong proliferation of T cells from normal SPF mice within 3 d, which was optimal
with 1-21 /o DC at high concentrations of responder cells (Fig. 1 a). The magnitude
ofthe response was similar to that obtained after a 2-d culture of similar T cell popu-
lations stimulated with optimal doses of the mitogen Con A (15). In contrast, un-
treated DC from the SPF animals did not cause significant stimulation. PEC, whether
untreated or infected with influenza virus, caused no T cell proliferation (Fig. 1 b) .
DC from lymph nodes of mice infected in vivo with influenza virus also stimu-
lated T cells from normal CBA mice to proliferate (Fig. 2 a). In this figure we show
that mAb HB42 to class II MHC (with IaK reactivity) blocked T cell stimulation
by DC effectively, which suggests that at 3 d of culture, much of the T cell prolifera-
tion measured reflects class II MHC-restricted T cells. A/X31-infected PEC did not
u
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FIGURE 1.
￿
Splenic DC infected with influen-
za virusin vitro induce proliferation ofT cells
from normal BALB/c mice. Responder T cells
purified from lymph nodes of normal SPF
mice were cultured for 3 d with syngeneic
stimulators: (a) 2,000syngeneic untreated DC
(p); 100-2,000 A/X31-infected DC (O); no
DC (40). (b) 250-4,000 A/X31-infected PEC
induced with Con A (O); no PEC (40).1258
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induced primary T cell proliferation, but were capable ofstimulating Tcells from
donors primed by infection in vivo, though less efficiently than DC (Fig. 3).
We wished to examine whetherDC were ableto generate a primary virus-specific,
CTL response. 60 replicate wells of Terasaki plates each received purified splenic
DC (103) infected with type A influenza virus X31 and purified T cells (10) from
lymph nodes ofnormal SPF mice, a combination giving high proliferative response
(Fig. 1 a). As controls, an aliquot ofthe same T cells were cultured with untreated
DC. After 5 d the replicate cultures were pooled and the cells tested for their ca-
pacity to lyse influenza-infected target cells. ResponderT cells sensitized by influenza-
infected DC, but not T cells in control cultures, strongly lysed influenza-infected
P815 targets compared with very low levels of lysis of untreated target cells (Fig.
4). This CTL lysis was class I MHC restricted; P815 cells do not express class II
MHC antigens and CBA (H-2k) thioglycollate-induced macrophages afterX31 in-
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FIGURE 2.
￿
DC isolated from lymph nodes of CBA mice
24 hafterinfluenza infection induces primaryandsecondary
Tcell proliferation. Tcells(50,000) enriched from lymph
nodes of (a) normal mice or (b) mice primed 2 mo previ-
ouslyby A/X31 intranasal infectionwere stimulated for3 d
with 500-2,000syngeneiclymphnode DC;normal DC (");
DC infected in vivo with A/X31 (O); or infected DC plus
mAbHB42 (AmericanTypeCultureCollection, 1985; HB42
is mAb26-8-16S selected by Sachset al.) to class II MHC.
Culture supernatant was used at 1:30 dilution (A).
FIGURE 3.
￿
Infected PEC from BALB/c mice induce sec-
ondary butnot primary T cell proliferation. Responder T
cells (105) purified from lymph nodes of (a) normal mice
or (b) mice primed 2 mo previously by A/X31 intranasal
infection were stimulated for 3 d with Con A-induced
purified PEC infected in vitrowith A/X31 (p)oruntreated
(/). Responsesto 1,250A/X31-infected DC (A)or untreated
DC (A)within this experiment areshownforcomparison.80-
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FIGURE 4.
￿
Primaryinduction of influenza virus-specific, and NP peptide-specific CTL by DC
in vitro. 60 identical hanging drop cultures (105 purified responder T cells from lymph nodes
of normal BALB/c mice) were stimulated for 5 d with: (a) DC infected with A/X31 influenza
virus; (b) DC pulsed with NP peptide 147-158 (Arg,55); (c) Con A-induced PEC (after removal
of DC) infected with A/X31 influenza virus; or (d) untreated DC . After pooling the cells in the
hanging drop cultures, their cytotoxicity wasassayed using a standard 5ICr release assay. Target
cells were "Cr-labeled P815 (H-2d) cells either untreated (O), A/X31 infected ("), or pulsed
with 10-7 M peptide 147-158 (Arg,56-) for 45 min before washing (A).
fection were not lysed (Table I). The X31-infected target cells were recognized by
CBA CTL (not shown). In other experiments, cells from control cultures ofT cells
stimulated to proliferate with DC exposed in vitro to an irrelevant antigen (FITC)
failed to lyse untreated or influenza-infected target cells (not shown). The primary
BALB/c CTL generated invitrowithDC exposed to influenzavirus also recognized
target cells pulsed with influenza NP peptide 147-158 (Arg156) (Fig. 4). This Kd-
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TABLE I
CTL Generated by Antigen DC Are MHC Restricted
Killer to target cell ratio = 10, 6-h assay.
T cells from lymph node of normal BALB/c mice were stimulated for 5 d with DC pretreated with 10-6
M influenza NP peptides 147-158 or 147-159 ArgI58- (R- ) in hanging drop cultures. Cytotoxic activity
was tested using P815 cells or CBA thioglycollate-induced MO, untreated, infected with X31 virus, or
pretreated with 10- 7 M peptides (see Materials and Methods).
Primed spleen cells were from BALB/c mice primed by intranasal infection with A/X31 virus and stimulat-
ed 5 d in vitro with A/X31-infected spleen cells.
a 1% A/X31 DC b 1% NPI147-1581 DC c 1% A/X31 PEG d 1% untreated DC
0 . ro, Q..
Percent target lysis
NP
147-158 NP
BALB/c CTL Stimulation Targets X31 (R- ) 147-158 Uninfected
Normal LNT' 1 % DC/NP 147-158R- P815 39 68 67 5
CBA MO 0.5 - 1 ND 0.6
Normal LNT' 1 % DC/NP 147-158 P815 31 56 56 4
CBA MO -0.9 -3.8 ND - 1 .2
Primed Spleen/X31 P815 63 80 79 16
spleen celst CBA MO 8 2 ND 21260
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restricted peptide is stronglyrecognized by CTLin BALB/c mice primed by influenza
infection (14, 16). Thus, antigen presentation by influenza-infected DC in vitro for
aprimary CTL response mimics the response resulting from in vivo infection. PEC
induced in vivo by Con A to express class II MHC molecules (P Allen, personal
communication) and infected with A/X31 influenza virus after removal ofDC did
not induce a primary CTL response in vitro (Fig. 4).
When responder T cells were derived from mice primed by influenza infection
(12), virus-infected PEC, as well as DC, induced strong secondary CTL responses
(Fig. 5), though macrophages were less efficient stimulators at the lower concentra-
tions of APC.
In Fig. 4 and Table I we show also that a strong primary antiviral CTL response
can be induced in hanging drop cultures when T cells from normal BALB/c mice
are stimulated with 1% DC pretreated with 10-6 M NP peptide 147-158 (Arg156-)
orthe natural NP sequence 147-158. Thelatter peptide inducedonlya slightly lower
CTL response than NP 147-158 (Arg156-). The resulting CTL strongly lysed the
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FIGURE 5.
￿
High potency of influenza-infected DC stimulator cells in generating a secondary
virus-specific CTL response in vitro. Responder spleen T cellswere from donor BALB/c mice
primed intranasally with 4 HAU ofA/X31 virus, 3 mo previously. 106 cells/ml were stimulated
with 100-1,000 DC or Con A-induced PEC, infected with influenzavirus. Forcomparison with
ourusual experimental conditions, T cells were also stimulated with A/X31-infected spleen cells
(20% of responder cell number). After 5 d CTL activity was assayed using 5'Cr-labeled P815
target cells, either infected with A/X31 ("), pulsed with 10-7 MNP peptide, 147-158 (Argl56-)
(A), or untreated (O).
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P815 target cells infected withA/X31 influenza virus, orthose pretreated with either
of the NP peptides. The level ofantiviral cytotoxicity induced by the peptide was
somewhat lower than with A/X31-infected DC. The NP is a major target epitope
restricted to Kd, but CTL from BALB/c mice also see other influenza proteins that
are Dd or Ld restricted. We cannot exclude that some Th reactivity to the NP pep-
tide at our high responder T cell concentration will contribute to the generation
of CTL.
Discussion
DC exposed to infectious A/X31 influenza virus caused potent proliferation of
T cells from normal SPF mice during a 3-d culture in as few as 12,500 lymphocytes
(to a great extent, class II MHC restricted), although the virus specificity of this
proliferation could only be inferred from its dependence on dose of viral antigen
and increased proliferation on secondary virus stimulation. The pooling ofhanging
drop cultures resulted in the identification of primary influenza-specific CTL re-
sponses, although CTL precursor frequencies were previously found to be very low
in our SPF mice ("1:106 total spleen cells or 1 :3 x 105 spleen T cells) (20). The
efficiency ofthe specific lysis in this system (reaching 50% with killer to target cell
ratios rangingfrom 1 to 10 indifferent experiments) suggests that avery high propor-
tion ofthe cells taken from the 5-d stimulated cultureswere specific CTL. This could
indicate that a higher proportion of T cells are able to recognize the viral peptide
than previously measured, and/or that these cells are dividing very rapidly under
our culture conditions. However, cells from 60 ofthe 20-,1 cultures were pooled be-
fore thecytotoxicassay was performed so that the total initial pool ofresponder cells
was 6 x 106. After 5 d ofculture we recover -20% ofthe starting cell numbers from
the pooled 60 hanging drops (ti106 cells) and we clearly select strongly for influenza-
specific CTL that have potent cytolytic activity. Ourlong-term CTL clones can lyse
-50% ofP815 target cells at a killer to target cell ratio of 0.5. These estimates of
the lytic efficiency of a single CTL may be low compared with freshly generated
CTL in short-term culture. It has been shown previously that one CTL can lyse
several target cellswithin a short time. We do not know whether occasional droplets
contained a high proportion of the CTL or whether most droplets were positive.
Hengel et al. (21) found that the frequency of HSVspecific CTL precursor cells in
polyclonally activated T cells from normal mice was as high as 1 in 200, and as a
result of this observation, they attempted to produce primary antigen-stimulated
CTL directed against virus-infected targets in vitro. This was achieved in 200-Al
cultures usingenrichedDC pulsed withhigh concentrations ofheat-inactivated virus
as stimulators, and a source of IL-2 (supernatants from Con A-stimulated spleen
cells). The cells were restimulated with virus after 2 d and the culture period was
extended to 7 d. The authors estimated that there was a frequency of between 1
in 500 and 1 in 10,000 HSVspecific CTL precursors in different strains of mice.
In our studies both the culture conditions and the efficiency ofantigen presenta-
tion were of major importance. Primary CTL responses were not generated with
the same cell combinations in similar proportions and at the same cell concentra-
tions (5 x 106/ml responder cells and 1% DC) in flasks or tubes (data not shown),
suggesting that the close cell/cell contacts and efficient gassing ofcells in hanging
drops may be essential for the observed response. Presentation of antigen by DC1262
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was also particularly effective as shown previously for a secondary in vitro CTL re-
sponse (10, 11) and by the fact that in some viral systems, and not in others, DC
can restore CTL responses in nonresponder H-2 mutant mice (11).
A very recent study (22) reports that peptide-specific CTL from C57BL/6 mice
can be induced in vitro by stimulation ofhigh numbers of total spleen cells (N6 x
10'/10 ml) with peptides or fragments ofOVA (after cyanogen bromide treatment
or trypsin treatment of OVA) and also by type A influenza NP peptide 365-380,
which is recognized by D'-restricted CTL (23). The NP peptide-specific CTL
generatedby Carbone et al. (22)were not obtained using influenza virus as a stimu-
lator and did not lyse influenza virus-infected cells. We find in this study that DC
pretreated with the 10-6-10-1 M Kd restricted NP peptide 147-158 or 147-158
(Argi56- ) result in the generation of CTL that also strongly lyse influenza
virus-infected target cells. Using thesame culture conditions described in reference
22, we could not generate BALB/c CTL specific for NP 147-158. This difference
may be due to our use of DC as APC compared with peptide treatment of total
spleen cells as APC for stimulation of the CTL precursor cells (22).
We observe that'I5C exposed to infectious influenza virus in a primary stimula-
tion generate CTL in vitro recognizingthe same NPepitope as that seenafter priming
of mice by infection (16). This suggests that the virus can enter the DC and that
the NP would be fragmented or expressed by the DC to enable stimulation ofCTL
precursor cells. The very low number ofmacrophages (3%) present in the purified
DC population was unlikely to contribute to the antigen presentation by DC ex-
posed to infectious virus. In any case, low numbers ofPEC macrophages were un-
able to stimulate a primary CTL response.
Our results showing the in vitro generation ofCTL from T cells ofnormal mice
by using virus-treated DC as APC also has practical implications for the study of
theT cell repertoire forviral proteins inhumanswhere thepossibilityofimmuniza-
tion with viral protein preparations is very limited. The hanging drop cultures are
also effective for human lymphoid cell cultures (15). Proliferative T cell responses
have already been obtained in normal human peripheral blood T cells on addition
of syngeneic DC exposed to HIV in vitro (24).
Summary
We used well-gassed hanging drop (20 pl) cultures with high concentrations of
purifiedT cells from normal BALB/c mice to examine whether dendriticcells (DC)
can induce primary antiviral proliferative T cell responses and generate virus-specific
CTL. We found that DC exposed to infectious influenza virus in vitro or in vivo
in smallnumbers (0.1-1%) resultedin strong proliferation ofresponder T cellswithin
3 d, and this was strongly inhibited by antibodies to class II MHC molecules. In
addition, in 5-d cultures, the influenza-treated DC generated CTL specifically able
to lyse influenza-infected syngeneic target cells bearing MHC class I antigens. The
most potent nucleoprotein (NP) epitope recognized byBALB/c CTLispeptide 147-158
(Argl56-) and influenza-infected DC in vitro stimulated CTL recognizing this pep-
tide, thus mimickingthe response in mice primed by intranasal influenza infection.
We also induced T cell proliferation and virus-specific CTL in cultures ofnormal
T cells by stimulating with DC pulsed with the natural NP sequence 147-158 or
the potent peptide 147-158 (Argls6- ). Small numbers of peritoneal exudate cells,MACATONIA ET AL.
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after activation with Con A to produce class II MHC expression and after removal
of DC with a specific mAb (33DI), did not lead to primary CTL generation but
initiated secondary stimulation in vitro. Our results using the hanging drop culture
method and DC as APC have implications for studying the T cell repertoire for
viral components in humans without the necessity of previous immunization.
We thank Dr. Ralph Steinman for providing the antibody to dendritic cells, 33D1, and Dr.
Siamon Gordon for the mAb to macrophages, F4/80.
Receivedfor publication 7 September 1988 and in revisedform 15 December 1988.
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